Advanced Proteome Therapeutics Corporation
APCH.V
TSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.48M | -278.00K | -209.70K | -76.20K | -467.80K |
| Total Depreciation and Amortization | 100.00 | 1.20K | 1.20K | 1.20K | 1.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.33M | -4.50K | -72.00K | -211.20K | 212.20K |
| Change in Net Operating Assets | -189.60K | 140.70K | 48.30K | 63.20K | 39.10K |
| Cash from Operations | -339.00K | -140.50K | -232.30K | -223.10K | -215.40K |
| Capital Expenditure | 0.00 | -700.00 | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -114.40K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 249.90K | -35.10K | -- | -- | -- |
| Cash from Investing | 135.50K | -35.80K | -- | 0.00 | 0.00 |
| Total Debt Issued | 46.00K | 45.00K | -- | -273.10K | 204.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 55.80K | -- | 279.00K | 0.00 |
| Repurchase of Common Stock | -40.40K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.60K | 100.80K | -- | 5.90K | 204.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -197.90K | -75.50K | -232.30K | -217.20K | -11.30K |
